Pricing Log in Create free account

Silo Pharma, Inc. (SILO) vs Silexion Therapeutics Corp (SLXN)

Silo Pharma, Inc. and Silexion Therapeutics Corp are both Biotechnology companies. Silo Pharma, Inc. and Silexion Therapeutics Corp are of similar size ($2.2M and $2.1M). Across the 9 metrics below, Silo Pharma, Inc. leads on 6 and Silexion Therapeutics Corp on 3.

Valuation

Metric SILO SLXN Biotechnology median
P/E n/m n/m 10.60
P/S 20.28 n/m 9.40
P/B 0.30 2.19 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.86 0.04 0.66
EV/Sales (52.27) n/m 9.02
Earnings yield (401.69%) (40,328.57%) (32.88%)
Free cash flow yield (268.42%) (12,933.04%) (23.13%)

Profitability

Metric SILO SLXN Biotechnology median
Gross margin 11.81% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (91.23%) (17,021.95%) (51.96%)
Return on assets (70.96%) (277.96%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SILO SLXN Biotechnology median
Revenue growth (TTM) 0.00% — 6.76%
EPS growth (last fiscal year) 57.98% 97.73% 29.88%
Revenue growth, 5-year CAGR 12.17% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SILO SLXN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.36 0.94 4.97
Net debt to EBITDA 1.61 0.38 1.01

Dividend

Metric SILO SLXN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SILO SLXN Biotechnology median
Market cap 2.05m 2.19m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack